Skip to main content

SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1232395 NEW YORK, NY

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,445,740
+$1,648,245 QoQ
Shares Held
103,616
-4.4% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#106
of 499 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 69% Shared 0% None 31%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $128,449,389 across 20 Biotechnology names. ARWR ranks #3 (6.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ARWR
Arrowhead Pharmaceuticals, Inc.
This page
103,616 $8,445,740

All Filings in ARWR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,445,740 103,616
2026-03-31 $6,797,495 108,413
2025-12-31 $10,530,914 158,622
2025-09-30 $9,414,873 272,974
2025-06-30 $4,426,796 280,177
2025-03-31 $3,564,002 279,749
2024-12-31 $5,273,606 280,511
2024-09-30 $4,356,099 224,889
2024-06-30 $3,957,211 152,259
2024-03-31 $4,295,662 150,198
2023-12-31 $3,066,915 100,226
2023-09-30 $2,694,496 100,279
2023-06-30 $3,579,729 100,385
2023-03-31 $2,171,877 85,507